SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid heated discussions following the death of Charlie Kirk, with community members debating the motivations and potential political implications. Some users are pointing fingers and alleging foul play, while others are calling for unity or expressing concern over increasing political division and violence. The renewed focus on the Epstein files is also a recurring theme within the discussions.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene ($CNC) is trending as investors discuss its potential turnaround, driven by upcoming presentations and anticipation of reaffirmed guidance at a healthcare summit. Community talking points include the stock being undervalued and poised for a significant rebound to previous price levels, with some suggesting a potential short squeeze. The stock's movement is also being discussed in the context of broader healthcare sector trends and potential policy changes.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies to reach 1500 watchers, triggering a planned token burn. Community members are excited about the burn, potential gains, and new utilities. Also, the community is discussing a recent airdrop with QKitty.

Wearable Devices Ltd. engages in the development of a non-invasive neural input technology that allows operation and control of digital devices using subtle finger movements and fingertip pressure. It offers Mudra band, a neutral input wristband. The company was founded by Asher Dahan, Guy Wagner, and Leeor Langer in March 2014 and is headquartered in Yokne'am Illit, Israel.

Wearable Devices Ltd

Wearable Devices ($WLDS) is trending due to its recent patent win and speculation of a potential buyout from Apple, fueling excitement among investors. The community is actively discussing the stock's volatility and potential for further gains, with some comparing it to other recent high-flying stocks with low floats. However, concerns about dilution and the company's cash position are also circulating.

Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending as investors discuss the company's potential for a valuation re-rate, especially with upcoming earnings on October 1st and management meetings generating buzz. Community members are focused on the company's growth potential and backlog conversion, drawing comparisons to other AI stocks while highlighting the undervaluation. Some are also monitoring a special meeting scheduled for September 30.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending due to discussions surrounding a recent convertible note offering, leading to concerns about dilution and management's transparency; the community is debating the necessity of the offering and its potential impact on the stock, with some speculating about acquisitions and manufacturing expansion. Despite the concerns, some community members view the dip as a buying opportunity, anticipating positive news or a potential short squeeze.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as the stock price hovers around multi-year lows, sparking debates about whether it's a value opportunity or a value trap. Community discussions revolve around the safety of the dividend yield and potential catalysts for a turnaround, with some investors expressing concerns about management and union contracts. Tariff risks, volume declines, and competition from companies such as Amazon are also being closely monitored.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending due to a leadership shakeup, including a new CEO and the return of co-founders to the board, sparking speculation about the company's future direction and potential short squeeze. The community is actively discussing the potential impact of these changes, with some highlighting the new CEO's background and others focusing on the high short interest and potential for a gamma squeeze. Broader market factors, such as upcoming CPI data and potential rate cuts, are also being considered as potential catalysts.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending due to the announcement that its Black Widow drone system has been approved for NATO's procurement catalog, potentially opening up new sales opportunities. While the community is excited about the NATO approval and potential revenue increases, some express concerns about the company's history and medium-long term fundamental support, with some viewing any price rebound as a selling opportunity. The overall drone sector is receiving attention, with investors comparing Red Cat to other companies in the space.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

KZIA is trending due to positive preclinical data showing its drug, paxalisib, may reverse immunotherapy resistance in triple-negative breast cancer; the community is discussing the potential for a short squeeze given the low float, high short interest, and analysts' price target upgrades. Investors are also awaiting further clinical trial updates and speculating about potential partnerships amidst the promising news and the company's need for capital.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IOVA .... $BMY  and $BNTX  moving along in their $~$11B JV....Ahhh....if only BMY looked at our(IOVA)product to JV...but so far, not to be(never say never though)...and others are always welcomed to JV  though ;)....yes...I know...not an apples to apples drug therapy/treatment comparison for Amtagvi but the goal is treatments.....saving patients with whatever product/treatment/therapy that patients can avail themselves to...I am always an optimist for advancing medical science but mgmt can wreck wonders if given enough rope....just some thoughts...glta 
 
&quot;The drug is already being tested in a Phase III lung cancer trial. 
Bristol Myers in June agreed to pay up to $11.1 billion to collaborate with BioNTech on the experimental drug, betting on a next-generation cancer immunotherapy that could take on rival Merck &amp; Co&#39;s best-selling drug Keytruda.&quot; 
 
https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-bristol-myers-immunotherapy-shows-encouraging-tumour-shrinkage-phase-ii-2025-09-08/

Drake Vlahakis

Robby Fuchs

A next-generation cancer immunotherapy by BioNTech and partner Bristol Myers Squibb led to encouraging tumour shrinkage in a mid-stage trial on small cell lung cancer that has started spreading, the German biotech firm said on Monday.

Reuters

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

StockTwits Web

Iovance Biotherapeutics Inc

Bristol-Myers Squibb Co.

BioNTech SE - ADR

  moving along in their $~$11B JV....Ahhh....if only BMY looked at our(IOVA)product to JV...but so far, not to be(never say never though)...and others are always welcomed to JV  though ;)....yes...I know...not an apples to apples drug therapy/treatment comparison for Amtagvi but the goal is treatments.....saving patients with whatever product/treatment/therapy that patients can avail themselves to...I am always an optimist for advancing medical science but mgmt can wreck wonders if given enough rope....just some thoughts...glta 
 
"The drug is already being tested in a Phase III lung cancer trial. 
Bristol Myers in June agreed to pay up to $11.1 billion to collaborate with BioNTech on the experimental drug, betting on a next-generation cancer immunotherapy that could take on rival Merck & Co's best-selling drug Keytruda." 
 
https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-bristol-myers-immunotherapy-shows-encouraging-tumour-shrinkage-phase-ii-2025-09-08/

@wwmeinc 
Sounds like very real competition- anyone know how this compares to TIL on a scientific level?

StockTwits for iOS

 
Sounds like very real competition- anyone know how this compares to TIL on a scientific level?